HeartSciences Files Prospectus Shelf Registration For $200M Mixed Securities
HeartSciences Inc HSCS
$4.05
▼ -8.58%
($-0.38)
🎈 Low Float
Open
$4.40
Prev Close
$4.43
Day Range
$3.97 – $4.48
52W Range
$1.63 – $5.25
Market Cap
$19.44M
Beta
1.77
EPS (TTM)
$-3.21
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2022-06-15 |
| Shares Out. | 3,900,000 |
| Website | heartsciences.com/ ↗ |
| Phone | 16822377781 |
| Employees | 14 |
| Revenue | $2,100 |
| Gross Profit | $1,340 |
| Net Income | -$3.2M |
| Free Cash Flow | -$6.8M |
| Total Assets | $3.7M |
| Total Liabilities | $5.8M |
| Equity | -$2.0M |
About HeartSciences Inc
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.
HeartSciences Inc is a publicly traded company under the ticker symbol HSCS on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
8 analysts (2026-09-01)